ViQi, Inc. Market Research Report
Company Overview
Name
ViQi, Inc.
Mission
ViQi exists to make large-scale image analysis fast, accessible, and easy for scientists to leverage computational resources to gain insights from image-based data, resulting in positive societal impact.
Founded
No information is available
Founders
No information is available
Key People
- Kathy Yeung, M.B.A. - Chief Executive Officer and Chair of Board
- Kristian Kvilekval, Ph.D. - Co-Founder, President, and Chief Architect
- Dmitry Fedorov, M.S. - Chief Technology Officer / Co-Founder
- Christian Lang, Ph.D. - Chief Information Officer / Co-Founder
- Ilya Goldberg, Ph.D. - Chief Science Officer
Headquarters
Santa Barbara, California, USA
Number of Employees
No information is available
Revenue
No information is available
Known For
ViQi, Inc. is known for using AI and cloud-based technology to revolutionize scientific image analysis, particularly in the fields of viral infectivity assays, high-content analysis, digital pathology, and environmental monitoring.
Products
AVIA™ Automated Viral Infectivity Assay
- Description: An innovative solution to automate and scale Plaque Assay, TCID50, and FFA.
- Key Features:
- Automates viral infectivity assays
- Scalable solution
- Based on AI for high accuracy
AUTOHCS™
- Description: Automated High Content Screening for large-scale phenotypic analysis.
- Key Features:
- Large-scale analysis capabilities
- Target phenotype identification
- Dose-response assessment
- Phenotypic relationship detection
- Cell painting
Digital Pathology
- Description: Provides quantification solutions for fibrosis and steatosis in pre-clinical digital pathology.
- Key Features:
- Automated fibrosis quantification
- Automated steatosis quantification
Environmental Monitoring
- Description: Simplifies user annotation systems resulting in robust environmental monitoring.
- Key Features:
- AI-based annotation
- Robust data analysis
Technology
Image Visualization and Analysis
Enables visualization and analysis of over 250 types of large-scale image formats in a centralized, cloud-based repository.
AI & Automated Classification
Provides AI-driven automated classification capabilities to streamline workflows and data processing.
Complex Data
Handles complex datasets and offers integrated solutions for data storage, visualization, and analysis.
Multi-User Collaboration
Facilitates collaboration among multiple users through centralized data access and sharing capabilities.
Recent Developments
New Partnerships
- June 19, 2024: Appointment of Dr. Tong-Ming Fu to the Scientific Advisory Board.
- September 15, 2022: Addition of Pascal Bamford, Ph.D. and Timothy Spicer, Ph.D. to the board of directors and scientific advisory board, respectively.
Product Launches
- July 2021: Launch of FibroNest 3.0 with additional quantification capabilities for common pathology parameters associated with fibrosis.
New Features
- March 28, 2022: Successful training of AI to identify infected from uninfected cells in brightfield microscopy for human coronavirus 229E.
Recent Activities
- February 8, 2024: Exhibition at SLAS conference showcasing AutoHCS with collaboration posters.
- December 7, 2023: Publication by PharmaNest of FibroNest™ product using ViQi's platform in Liver International.
- July 14, 2023: Co-publication of research paper on viral infectivity assay using brightfield microscopy and machine learning in SLAS Technology.
Contact Information
Address
315 Meigs Road, Suite A261, Santa Barbara, CA, 93109
sales@viqiai.com
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.
For detailed information on ViQi's offerings, technological advancements, and further inquiries, visit their official website or reach out through the contact details provided.
